Shikonin suppresses proliferation of osteosarcoma cells by inducing ferroptosis through promoting Nrf2 ubiquitination and inhibiting the xCT/GPX4 regulatory axis
2024

Shikonin and Its Role in Inducing Ferroptosis in Osteosarcoma Cells

publication Evidence: moderate

Author Information

Author(s): Huang Rui, Chu Dawei, Shi Jiandang, Xu Ruiqing, Wang Kun

Primary Institution: General Hospital of Ningxia Medical University

Hypothesis

Does shikonin induce ferroptosis in osteosarcoma cells through the Nrf2/xCT/GPX4 regulatory axis?

Conclusion

Shikonin effectively suppresses osteosarcoma cell proliferation by inducing ferroptosis via the Nrf2/xCT/GPX4 pathway.

Supporting Evidence

  • Shikonin significantly suppressed osteosarcoma cell proliferation in a dose-dependent manner.
  • Ferroptosis was confirmed as a mechanism of action for shikonin in osteosarcoma cells.
  • Shikonin treatment led to increased levels of reactive oxygen species and lipid peroxidation in the cells.
  • Shikonin downregulated the expression of xCT and GPX4, key proteins involved in ferroptosis.

Takeaway

Shikonin is a natural compound that can help kill cancer cells by making them undergo a special type of cell death called ferroptosis.

Methodology

The study involved in vitro experiments using osteosarcoma cell lines treated with shikonin to assess cell proliferation, ferroptosis markers, and the Nrf2/xCT/GPX4 pathway.

Limitations

The in vivo anti-tumor effect of shikonin remains to be verified.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fphar.2024.1490759

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication